BACKGROUND: Chronic subclinical inflammation, manifesting as elevated levels of inflammatory markers such as C-reactive protein (CRP), predicts future atherothrombotic events. The pathophysiology of low-grade inflammation is complex, and multiple intercorrelated conditions have been associated with elevated CRP. METHODS: Principal factor analysis was used to investigate clustering of variables associated with elevated CRP using data from 1435 subjects without known coronary disease. Components of the metabolic syndrome, uric acid, liver enzymes, pulmonary function tests, smoking status, cardiorespiratory fitness (measured by maximal treadmill test), and high-sensitivity C-reactive protein were determined in each subject. RESULTS: Factor analysis identified three factors, which explained 51.0% of the total variance in the dataset (24.4% factor 1, 17.3% factor 2, and 9.3% factor 3). Based on factor loadings of >or=0.5, these factors were interpreted as (1) "metabolic factor" including BMI, fasting glucose, HDL cholesterol, triglycerides, systolic blood pressure, and uric acid; (2) a cardiorespiratory factor that included fitness level, forced expiratory volume in 1s and sex; and (3) "smoking" factor that included cigarette smoking and age. Each of these factors was significantly associated with the presence of high-risk CRP (>or=3mg/L) in the study population. The ability of a multivariate model that included these three factors to predict high-risk CRP was comparable to a model containing the original 10 variables (area under the receiver-operator characteristics curve 0.7 vs. 0.72, respectively). CONCLUSION: Metabolic perturbations, cardiorespiratory fitness, and smoking are separate and largely independent factors in the pathophysiology of chronic, low-grade inflammation.
BACKGROUND: Chronic subclinical inflammation, manifesting as elevated levels of inflammatory markers such as C-reactive protein (CRP), predicts future atherothrombotic events. The pathophysiology of low-grade inflammation is complex, and multiple intercorrelated conditions have been associated with elevated CRP. METHODS: Principal factor analysis was used to investigate clustering of variables associated with elevated CRP using data from 1435 subjects without known coronary disease. Components of the metabolic syndrome, uric acid, liver enzymes, pulmonary function tests, smoking status, cardiorespiratory fitness (measured by maximal treadmill test), and high-sensitivity C-reactive protein were determined in each subject. RESULTS: Factor analysis identified three factors, which explained 51.0% of the total variance in the dataset (24.4% factor 1, 17.3% factor 2, and 9.3% factor 3). Based on factor loadings of >or=0.5, these factors were interpreted as (1) "metabolic factor" including BMI, fasting glucose, HDL cholesterol, triglycerides, systolic blood pressure, and uric acid; (2) a cardiorespiratory factor that included fitness level, forced expiratory volume in 1s and sex; and (3) "smoking" factor that included cigarette smoking and age. Each of these factors was significantly associated with the presence of high-risk CRP (>or=3mg/L) in the study population. The ability of a multivariate model that included these three factors to predict high-risk CRP was comparable to a model containing the original 10 variables (area under the receiver-operator characteristics curve 0.7 vs. 0.72, respectively). CONCLUSION: Metabolic perturbations, cardiorespiratory fitness, and smoking are separate and largely independent factors in the pathophysiology of chronic, low-grade inflammation.
Authors: B T Bikman; T L Woodlief; R C Noland; S L Britton; L G Koch; R M Lust; G L Dohm; R N Cortright Journal: Int J Sports Med Date: 2009-06-30 Impact factor: 3.118
Authors: Gabriel Contreras; Bo Hu; Brad C Astor; Tom Greene; Thomas Erlinger; John W Kusek; Michael Lipkowitz; Julia A Lewis; Otelio S Randall; Lee Hebert; Jackson T Wright; Cynthia A Kendrick; Jennifer Gassman; George Bakris; Joel D Kopple; Lawrence J Appel Journal: J Am Soc Nephrol Date: 2010-09-23 Impact factor: 10.121
Authors: Jeanette M Bennett; Ronald Glaser; William B Malarkey; David Q Beversdorf; Juan Peng; Janice K Kiecolt-Glaser Journal: Brain Behav Immun Date: 2011-12-01 Impact factor: 7.217
Authors: Lisa M Bodnar; Katherine L Wisner; James F Luther; Robert W Powers; Rhobert W Evans; Marcia J Gallaher; P K Newby Journal: Public Health Nutr Date: 2011-12-08 Impact factor: 4.022
Authors: Vittoria D'Esposito; Michele Francesco Di Tolla; Manuela Lecce; Francesco Cavalli; Michele Libutti; Saverio Misso; Serena Cabaro; Maria Rosaria Ambrosio; Alessia Parascandolo; Bianca Covelli; Giuseppe Perruolo; Mario Sansone; Pietro Formisano Journal: Front Nutr Date: 2022-06-24
Authors: Thomas C Baghai; Gabriella Varallo-Bedarida; Christoph Born; Sibylle Häfner; Cornelius Schüle; Daniela Eser; Peter Zill; André Manook; Johannes Weigl; Somayeh Jooyandeh; Caroline Nothdurfter; Clemens von Schacky; Brigitta Bondy; Rainer Rupprecht Journal: Int J Mol Sci Date: 2018-06-12 Impact factor: 5.923